MAPT and Alzheimer disease: Indeed, growing evidence supports the hypothesis that insulin resistance and reduced brain glucose metabolism may promote a “shift” towards the amyloidogenic pathway and tau phosphorylation, in the complex interplay of AD pathophysiology [14, 193, 194].